 |
Previous Article | Next Article 
The Journal of Neuroscience, January 1, 2002, 22(1):114-122
Multiple Channel Interactions Explain the Protection of
Sympathetic Neurons from Apoptosis Induced by Nerve Growth Factor
Deprivation
Shuli
Xia1, 3,
Patricia
A.
Lampe2,
Mohanish
Deshmukh2,
Aizhen
Yang1, 3,
Barry S.
Brown4,
Steve M.
Rothman1, 2,
Eugene M.
Johnson Jr1, 2, 3, and
Shan Ping
Yu1, 3
Departments of 1 Neurology and 2 Molecular
Biology and Pharmacology and 3 Center for the Study of
Nervous System Injury, Washington University School of Medicine, St.
Louis, Missouri 63110, and 4 DuPont Pharmaceuticals
Research Laboratories, General Pharmacology, Wilmington, Delaware 19880
 |
ABSTRACT |
We investigated the neuroprotective properties of two M-type
K+ channel blockers, linopirdine and its analog
XE991, in rat sympathetic neurons deprived of nerve growth factor
(NGF). Linopirdine and XE991 promoted sympathetic neuronal survival
48-72 hr after NGF withdrawal in a concentration-dependent manner.
Both drugs prevented neuronal apoptosis by blocking the pathway leading
to the release of cytochrome c and development of
"competence-to-die" after NGF deprivation. Fura-2
Ca2+ imaging showed no significant difference in
intracellular free Ca2+
([Ca2+]i) in the presence or
absence of NGF; linopirdine and XE991, on the other hand, caused
membrane depolarization and increases in
[Ca2+]i. Whole-cell recordings showed
that linopirdine and XE991 selectively blocked the M current at
neuroprotective concentrations, although they additionally inhibited
other K+ currents at high concentrations. Membrane
depolarization and [Ca2+]i increases
induced by linopirdine and XE991 were blocked by the
Na+ channel blocker tetrodotoxin (TTX) or by the
L-type Ca2+ channel antagonist nifedipine. TTX and
nifedipine also prevented the neuroprotection elicited by linopirdine
or XE991.
We propose that Na+ channel activation amplifies the
membrane depolarization produced by M channel blockade and is essential for subsequent Ca2+ entry via the L-type
Ca2+ channel. The interaction of these three classes
of ion channels highlights an integrated anti-apoptosis mechanism in
sympathetic neurons.
Key words:
apoptosis; calcium; M-type potassium channel; nerve
growth factor; sympathetic neuron; cortical neuron; tetrodotoxin; linopirdine; XE991
 |
INTRODUCTION |
Apoptosis is an important regulatory
process during the development of the nervous system. It also
contributes to neuronal loss in stroke, trauma, and some
neurodegenerative disorders (Oppenheim, 1991 ; Choi, 1996 ; Henderson,
1996 ). Elevation of extracellular K+
([K+]o) blocks
apoptosis in neurons from a variety of peripheral and central
locations, including sympathetic ganglia, hippocampus, neocortex,
cerebellum, and dorsal root ganglia (Gallo et al., 1987 ; Collins and
Lile, 1989 ; Koike et al., 1989 ; Collins et al., 1991 ; Franklin et al.,
1995 ; Galli et al., 1995 ; Pike et al., 1996 ; Tong et al., 1997 ; Yu et
al., 1997 ; Colom et al., 1998 ). Two different mechanisms have been
proposed to explain the anti-apoptotic effect of high
[K+]o. In
sympathetic neurons, cerebellar granule cells, and some other types of
neurons, the anti-apoptotic effect of elevated [K+]o has been
shown to be mediated by increased intracellular
Ca2+ concentration
([Ca2+]i) as a
result of membrane depolarization and activation of the L-type
voltage-dependent Ca2+ channels (Gallo et
al., 1987 ; Collins and Lile, 1989 ; Koike et al., 1989 ; Franklin et al.,
1995 ; Galli et al., 1995 ; Tong et al., 1997 ). In contrast, recent work
on central neurons, such as neocortical neurons, and several peripheral
cells supports the idea that elevated extracellular
K+, or K+
channel blockers, such as tetraethylammonium (TEA), suppress apoptosis
attributable to prevention of K+
efflux and intracellular K+ loss (Yu et
al., 1997 , 1998 , 1999 ; Colom et al., 1998 ; Dallaporta et al., 1998 ;
Hughes and Cidlowski, 1999 ). This protective effect can be independent
of changes in
[Ca2+]i (Yu et
al., 1997 , 1998 , 1999 ).
Given these results, we wondered whether newly developed, selective
M-type K+ channel blockers would be
anti-apoptotic in cultured rat sympathetic neurons after nerve growth
factor (NGF) deprivation, and, if so, whether the neuroprotective
mechanism would be mediated by elevation of
[Ca2+]i or direct
inhibition of K+ efflux. Sympathetic
neurons undergo apoptosis within 48-72 hr after NGF withdrawal
(Edwards et al., 1991 ; Deckwerth and Johnson, 1993 ; Deshmukh and
Johnson, 1997 ; Werth et al., 2000 ). It has been shown that NGF
deprivation induces two parallel processes that are sufficient to
induce apoptotic death: (1) protein synthesis-dependent, caspase-independent loss of mitochondrial cytochrome c; and (2) the
development of "competence-to-die," which requires no
macromolecular synthesis (Deshmukh and Johnson, 1998 ). This cell death
can be inhibited by cycloheximide (CHX),
boc-aspartyl(OMe)-fluoromethylketone (BAF), and some other
neuroprotective agents (Martin et al., 1988 ; Rydel and Greene, 1988 ;
Koike et al., 1989 ; Franklin et al., 1995 ; Deshmukh et al., 1996 ;
McCarthy et al., 1997 ).
Linopirdine
[3,3-bis(4-pyridinylmethyl)-1-phenylindolin-2-one;DUP996] and its
analog XE991 [10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone] are
potent blockers of M-type K+ channels in a
variety of neurons (Costa and Brown, 1997 ; Schnee and Brown, 1998 ; Wang
et al., 1998 , 2000 ; Brown and Yu, 2000 ). They are also representative
of a class of cognition-enhancing compounds that increase the release
of neurotransmitters (Kristufek et al., 1999 ). The neuroprotective
potential of these compounds, however, has not been investigated
previously. The present study demonstrates that M channel blockers are
highly neuroprotective against NGF deprivation-induced apoptosis in
sympathetic neurons; the protection requires block of the M channel, as
well as activation of voltage-gated Ca2+
and Na+ channels.
 |
MATERIALS AND METHODS |
Sympathetic neuronal cultures. Primary cultures of
sympathetic neurons from superior cervical ganglion were prepared by
dissecting tissue from rat fetuses on embryonic day 21 as described
previously (Johnson and Argiro, 1983 ; Martin et al., 1988 ).
Briefly, the ganglia were placed in Leibovitz's L-15 medium with
L-glutamine (Life Technologies,
Gaithersburg, MD), digested with 1 mg/ml collagenase (Worthington,
Freehold, NJ) for 30 min at 37°C, followed by another 30 min
digestion in trypsin (Worthington), and then resuspended in modified
HBSS. The digestion was stopped by AM50, which contained minimum
essential medium with Earle's salts (no
L-glutamine), 10% fetal calf serum (HyClone,
Logan, UT), 2 mM glutamine, 20 mM floxuridine, 20 mM
uridine, 100 U/ml penicillin, 100 µg/ml streptomycin, and 50 ng/ml
mouse 2.5 S NGF (Harlan Sprague Dawley, Indianapolis, IN). Ganglia were
then dissociated into a suspension of individual cells and preplated on
a 100 mm Falcon or Primaria culture dish (Becton Dickinson, Lincoln
Park, NJ). After 2 hr, the medium containing the unattached cells,
virtually all neurons, was removed and triturated again.
The cell suspension was plated on 24-well tissue culture plates
(Costar, Wilmington, MA), glass-bottomed 35 mm dishes (Corning, Corning, NY), or two-well chamber slides (Nunc, Naperville, IL) that
have been coated previously with collagen and air dried. Cells were
allowed to attach for 0.5-2 hr. Approximately 1500 cells, or 25% of
the cells obtained from a single ganglion, were plated into each well.
Cultures were then incubated at 37°C in 5% CO2
and 95% air atmosphere.
Neocortical cultures. Mixed cortical cultures (containing
neurons and a confluent glia bed) were prepared as described previously (Rose et al., 1993 ). Dissociated neocortices obtained from fetal mice
were plated onto a previously established glial monolayer at a density
of 0.35-0.40 hemispheres per milliliter on 24-well plates
(Falcon or Primaria), in Eagle's minimal essential medium (Earle's
salts) supplemented with 20 mM glucose, 5% fetal
bovine serum, and 5% horse serum. Medium was changed after 1 week to MEM containing 20 mM glucose and 10% horse
serum, as well as cytosine arabinoside (10 µM) to inhibit cell division. Experiments were performed after 10-12 d in culture.
Neuronal death-survival assay. Sympathetic neurons were
plated on 24-well plates as stated above or, alternatively, on two-well chamber slides. The cultured sympathetic neurons could be killed by
adding medium (AM0) lacking NGF and containing 0.05% goat anti-NGF. AM0 caused the death of the neurons over a period of 48-72 hr. For
experiments with potassium channel blockers, drugs were added at the
time when NGF was removed. To quantify neuronal death and survival, the
cultures were fixed in 4% paraformaldehyde or 10% formalin in
PBS, stained with toluidine blue, and counted using a
phase-contrast microscope. Neurons were scored as viable if they had a
clear nucleolus and nuclei and were clearly stained with toluidine.
Cortical neuronal cell death induced by staurosporine (0.1 µM, 24 hr) was assessed in 24-well plates by measuring
lactate dehydrogenase (LDH) released into the bathing medium (MEM
plus 20 mM glucose and 30 mM
NaHCO3) using a multiple plate reader (Molecular
Devices, Sunnyvale, CA). Neuronal loss is expressed as a percentage of
LDH release measured in each experimental condition normalized to
negative (sham wash) and positive (complete neuronal death induced by
24 hr exposure to 300 µM NMDA) controls.
Immunohistochemistry. Sympathetic neuronal cultures were
immunostained as described previously (Easton et al., 1997 ; Deshmukh and Johnson, 1998 ). Briefly, cells were grown on collagen-coated, two-well glass chamber slides. For staining, cultures were washed once
with PBS and fixed with 4% paraformaldehyde in PBS for 30 min at
4°C, followed by washing three times with Tris-buffered saline (TBS)
(0.9% NaCl and 100 mM Tris-HCl, pH 7.6). After
incubation in blocking buffer (5% goat serum and 0.3% Triton X-100 in
TBS) for 30 min at room temperature (21 ± 1°C), cultures were
exposed to the anti-cytochrome c primary antibody (PharMingen, San
Diego, CA) overnight at 4°C. The primary antibody was diluted 1:1000 (final concentration of 0.5 µg/ml) in blocking buffer. Cells were then washed three times with TBS and incubated with an anti-mouse FITC-conjugated secondary antibody (1:300 with a final concentration of
2 µg/ml) (Jackson ImmunoResearch, West Grove, PA) for 2-4 hr at
4°C. Finally, the cells were washed twice in TBS and stained with the
nuclear dye bisbenzimide (Hoechst 33258 used at 1 µg/ml; Molecular
Probes, Eugene, OR) for 15 min at room temperature. After washing twice
with TBS, samples were mounted (50% glycerin and 0.1%
paraphenylenediamine in PBS) and examined under fluorescence microscopy.
Cell counts for loss of cytochrome c. After 5-7 d in the
NGF-containing medium, cultured neurons were deprived of NGF in the presence or absence of linopirdine or XE991. Parallel control cultures
were deprived of NGF in the presence of protein synthesis inhibitor CHX
or the caspase inhibitor BAF (Enzyme Systems Products, Livermore, MO).
Forty-eight hours after NGF withdrawal, cultures were fixed and
immunostained with anti-cytochrome c antibodies as stated above.
Sympathetic neurons maintained with NGF exhibited a punctate staining
pattern with anti-cytochrome c antibodies, and this staining pattern
became very diffuse after NGF deprivation (Deshmukh and Johnson, 1998 ).
For each condition, the number of cells that lost the punctate staining
pattern for cytochrome c was counted by a blinded observer, from a
random sampling of 100-150 cells.
Microinjections and quantification of cell death.
Microinjection of cytochrome c into sympathetic neurons was performed
as described previously (Deshmukh and Johnson, 1998 ). Briefly,
sympathetic neuronal cultures were grown in the appropriate medium on
collagen-coated, 35 mm dishes and then switched to Leibovitz's L-15
medium containing 100 µg/ml penicillin and 100 µg/ml streptomycin
before injection. To identify the injected cells, the injection
solution (100 mM KCl and 10 mM Kpi, pH 7.4) contained
rhodamine dextran (4 mg/ml). The solution containing rhodamine dextran
with or without cytochrome c (15 mg/ml, diluted in water and freshly
prepared for each experiment) was injected into the cytoplasm of
neurons by using Femtotips needles (Eppendorf Inc., Madison, WI).
Immediately after the injections, the number of injected viable cells
was determined by counting the number of rhodamine-positive cells that
had intact, phase-bright cell bodies. Cultures were then switched to
the appropriate medium, and, at various time after injections, the
number of remaining viable injected neurons was determined by using the
same counting criterion.
Calcium imaging. After 12-16 hr of treatment, we used
ratiometric fluorescence imaging with fura-2 AM (Teflabs, Houston, TX) to measure the intracellular free Ca2+
concentration,
[Ca2+]i, in
neuronal cell bodies. Fura-2 AM (5 µM) was bath
loaded into neurons at 37°C for 1 hr, followed by another 1 hr of
incubation at room temperature. Fluorescent cells were imaged on an
inverted microscope (Diaphot; Nikon, Melville, NY), using a 40×, 1.3 numerical aperture fluorite oil immersion objective (Nikon) and a
cooled CCD camera (Sensys; Photometrics, Tucson, AZ). A 75 W xenon arc lamp provided fluorescence excitation. Ratio images were obtained by
acquiring pairs of images at alternate excitation wavelengths (340 and
380 nm) and filtering the emission at 510 nm. Image acquisition and
processing were controlled by a computer connected to the camera and
filter wheel (Metafluor; Universal Imaging Corporation, West Chester,
PA). A background image for each wavelength was acquired from a field
lacking fluorescent neurons and subtracted from each fluorescent image.
The actual [Ca2+]i
in a region of interest was calculated from the following formula:
[Ca2+]i = KdB(R Rmin)/(Rmax R), where Kd is the
fura-2 dissociation constant for Ca2+ (224 nM), R is the average ratio of
fluorescence intensity at 340 and 380 nm wavelength in the region of
interest, Rmax and Rmin are the ratios at saturating
Ca2+ and zero
Ca2+, respectively, and B is
the ratio of the fluorescence intensity of the 380 nm wavelength at
zero and saturating Ca2+ (Grynkiewicz et
al., 1985 ). Rmin,
Rmax, and B for fura-2 on
our microscope were determined by imaging a droplet (20 µl) that
evenly filled the microscopic field and contained 0 (10 mM EGTA) or 2 mM added
Ca2+, 25 µM
fura-2/K+, and an artificial intracellular
solution. The concentration of fura-2 in the calibration solution was
selected to provide similar fluorescence intensity to that of
dye-loaded neurons.
Electrophysiology. Whole-cell recording was used to measure
the membrane potential and potassium currents in sympathetic neurons. Neurons were cultured for 7-11 d in 35 mm dishes and placed on the
stage of an inverted microscope (Diaphot; Nikon) that allowed us to
record under direct vision. We used an EPC-7 amplifier (List Electronic, Darmstadt, Germany); patch electrodes had tip
resistances between 7 and 10 M (fire polished). The extracellular
solution contained (in mM): 115 NaCl, 2.5 KCl,
2.0 MnCl2, 10 HEPES, 0.1 BAPTA, and 10 D-glucose. Tetrodotoxin (TTX) (0.1 µM) was added in some of the experiments.
Mn2+ was chosen to replace
Ca2+ to block
Ca2+ channel activation. The electrode
solution contained (in mM): 120 KCl, 1.5 MgCl2, 1.0 CaCl2, 2.0 Na2-ATP, 1.0 BAPTA, and 10 HEPES. After forming
gigaohm seals, whole-cell recording mode was established by
slight suctions. Current and voltage traces were displayed and stored
on a computer using the data acquisition-analysis program package
PULSE (Heka Electronik, Lambrecht/Pfalz, Germany).
Reagents. All reagents were purchased from Sigma (St. Louis,
MO) unless otherwise stated. Linopirdine and XE991 were kindly provided
by DuPont Pharmaceuticals (Wilmington, DE).
Statistics. Significant changes were determined if the
two-tailed p value was at least <0.05. Multiple comparisons
were performed using one-way ANOVA, followed by Tukey's test using
commercial InStat (GraphPad Software Inc., San Diego, CA). Data were
represented as mean ± SEM.
 |
RESULTS |
M channel blockers protected sympathetic neurons from programmed
cell death induced by NGF deprivation
The M channel blocker linopirdine or XE991 showed marked
neuroprotection against apoptosis induced by NGF withdrawal. Within 48 hr of NGF deprivation, 90% of sympathetic neurons underwent apoptosis
as indicated by cell shrinkage, phase darkness, irregular membranes,
and neurite fragmentation (Fig.
1B). In the presence of
linopirdine or XE991, the NGF-deprived neurons maintained their phase-bright appearance and intact neurites and looked similar to
neurons in NGF-maintained medium (Fig.
1A,C,D). The protective effect of both linopirdine and XE991 was concentration dependent (Fig.
2). After 48 hr incubation in
NGF-deprived medium, >90% of the neurons survived with 30 µM linopirdine or 50 µM
XE991. The EC50 values of linopirdine and XE991
against NGF deprivation-induced cell death were 3.5 and 0.7 µM, respectively (Fig. 2).

View larger version (187K):
[in this window]
[in a new window]
|
Figure 1.
Linopirdine and XE991 promoted survival of
sympathetic neurons deprived of NGF. A, Healthy
sympathetic neurons maintained in the presence of NGF showed
phase-bright appearance in phase-contrast photographs.
B, Cells maintained in NGF for 5 d after plating
and then deprived of NGF for 2 d had irregular membranes and
neurite fragmentation indicative of apoptosis. C,
D, Neuronal death was prevented in NGF-deprived
sympathetic neurons when 20 µM linopirdine
(C) or 5 µM XE991
(D) was added in the medium at the time of NGF
withdrawal. Photographs were taken 2 d after NGF deprivation.
Scale bar, 30 µm.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
Figure 2.
Dose-dependent protective effects of linopirdine
and XE991 on sympathetic neuronal apoptosis. Cultures were fixed and
stained with toluidine blue, and live cells were counted under a
microscope. A, Linopirdine protected sympathetic neurons
from apoptosis in a dose-dependant manner. At 30 µM,
linopirdine showed the most potent protective effect. The
inset is an exponential curve-fitting plot on a log
axis; the fitted curve gives an EC50 of 3.5 µM for the effect of linopirdine on cell survival.
B, XE991 at 50 µM completely protected
sympathetic neurons from death. The inset of fitted
curve yields an EC50 of 0.7 µM for the effect
of XE991 on cell survival. Depicted are the mean ± SEM value for
each condition.
|
|
Mediation of the neuroprotection by M-type potassium channels
The M channel is a non-inactivating
K+ channel (Brown and Yu, 2000 ). Previous
work in hippocampal neurons showed that linopirdine blocked the M
current with an IC50 of 2.4 µM
(Schnee and Brown, 1998 ). In sympathetic neurons, the M current was
blocked by 54 ± 5% by 20 µM linopirdine
(n = 10; p < 0.05) and 62 ± 8%
by 10 µM XE991 (n = 10;
p < 0.05) (Fig. 3). At
concentrations that blocked approximately half of cell death,
linopirdine (5 µM) and XE991 (3 µM) suppressed 10 ± 1 and 15 ± 1%
M current (n = 5 and 7 respectively; p < 0.05); at these concentrations, they showed little inhibitory effect
on other potassium currents (Fig. 4).
Higher concentrations of linopirdine (20 µM)
and XE991 (10 µM), nevertheless, suppressed the
outward delayed rectifier K+ current
IK (Fig. 4). Neither linopirdine (20 µM) nor XE991 (10 µM)
showed significant inhibitory effect on the A-type
K+ current,
IA, when evaluated at a membrane
potential of 20 mV (Fig. 4). Both drugs did, however, attenuate
~20-30% of IA current triggered by
voltage steps to positive membrane potentials (+20 or +40 mV). The
pharmacological profile of linopirdine and XE991 appeared similar in
normal sympathetic neurons or neurons deprived of NGF for 7-10 hr
(Figs. 3, 4). The selective IA channel
blocker 4-aminopyridine (4-AP) (0.1 and 1.0 mM)
showed no protective effect against the NGF deprivation-induced
apoptosis (Fig. 4), supporting our hypothesis that
IA was not involved in the
neuroprotection.

View larger version (21K):
[in this window]
[in a new window]
|
Figure 4.
Effects of linopirdine and XE991 on
IK and IA
currents in sympathetic neurons. A, The outward delayed
rectifier IK was not affected by 5 µM linopirdine and 3 µM XE991 added into
the medium for up to 20 min. IK was partly
depressed by 20 µM linopirdine (27 ± 5%
inhibition; n = 8; p < 0.05)
and by 10 µM XE991 (18 ± 2% block;
n = 8; p < 0.05). Similar
inhibitory effects were seen in neurons deprived of NGF for 7-10 hr
(n = 5 for each test).
IK was triggered by a voltage step from the
holding potential of 70 to +40 mV for 300 msec; steady-state current
was measured for the drug effect. *p < 0.05 indicates significant difference from the control current recorded
before drug application. B, Linopirdine (20 µM) and XE991 (10 µM) showed no significant effect on the A-type
K+ current triggered by a voltage step from 110 to
20 mV. The IA peak current was measured
for the drug effect (n = 8 for each group).
C, The A-type K+ channel blocker 4-AP
(0.1 and 1.0 mM) showed no protection against the NGF
deprivation-induced cell death; 4-AP at tested concentrations was not
toxic to SCG neurons. *p < 0.05 indicates
significant difference from controls with NGF.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
Figure 3.
Inhibition of the M current by linopirdine and
XE991 in sympathetic neurons. A, In whole-cell
recording, the membrane potential was held at 30 mV to allow M
channels to stay in an open state; when the membrane was hyperpolarized
to 50 mV, a slow inward current was generated, representing the
time-dependent closing of M channels; during depolarizing back to 30
mV, an outward current associated with channel reopening appeared.
After 5 min application of 10 µM XE991, the M current was
substantially suppressed. B, The inhibitory effects of
20 µM linopirdine (n = 7) and 10 µM XE991 (n = 5) on M currents in
normal sympathetic neurons or neurons deprived of NGF for 7-10 hr.
*p < 0.05 indicates significant difference from
the current before drug application (control) (paired t
test).
|
|
In contrast to sympathetic neurons, cortical neurons in our culture
condition often do not have detectable M current (Fig. 5). In agreement with this observation,
linopirdine (1-10 µM) and XE991 (1-10 µM)
showed no neuroprotective effect against apoptosis in cortical neuronal
cultures (Fig. 5).

View larger version (23K):
[in this window]
[in a new window]
|
Figure 5.
Lack of neuroprotective effects of linopirdine and
XE991 in neocortical cultures. A, In cultured cortical
neurons, little or small M current was detected, even with voltage
steps of wide ranges specific for M channel activation (Brown and
Adams, 1980 ; Yu, 1995 ). B, The membrane-permeable
sphingomyelin metabolite C2-ceramide produces apoptosis in
cortical neurons, which can be attenuated by K+
channel blockers TEA and clofilium (Yu et al., 1999 ). Cortical cultures
were exposed to 25 µM C2-ceramide alone or
coapplied with linopirdine or XE991. Cell death was assayed 48 hr later
by LDH release. The C2-ceramide-induced cell death was not
affected by linopirdine (1-10 µM); linopirdine alone
showed no influence on cell viability (n = 12 cultures for each test). C, XE991 (1-10
µM) showed no protective effect on
C2-ceramide-induced apoptosis; XE991 alone was not toxic to
cortical cells (n = 12 cultures for each test).
MK-801 (1 µM) was added into the medium to prevent NMDA
receptor-mediated excitotoxicity. Complete neuronal death was achieved
by 300 µM NMDA in the absence of MK-801.
|
|
Linopirdine and XE991 prevented cytochrome c translocation from
mitochondria to cytosol
Because linopirdine and XE991 protected sympathetic neurons from
apoptotic cell death under NGF deprivation, we examined whether these
compounds blocked the pathway leading to the release of cytochrome c
and/or the development of competence-to-die (Deshmukh and
Johnson, 1998 ). Immunocytochemistry showed that, in NGF-containing medium or in NGF-depleted medium containing CHX, >90% of the neurons possessed intact mitochondrial cytochrome c by exhibiting a punctate staining pattern. Cells deprived of NGF and treated with the caspase inhibitor BAF showed a diffused cytoplasmic pattern (Deshmukh and Johnson, 1998 ). Cultures treated with linopirdine or XE991 under
NGF deprivation retained intact mitochondrial cytochrome c in over 90%
of the cells (Fig. 6). Therefore, the
K+ channel blockers inhibited neuronal
apoptosis by acting at a point before the release of cytochrome c from
mitochondria to cytosol.

View larger version (50K):
[in this window]
[in a new window]
|
Figure 6.
Linopirdine and XE991 prevented cytochrome c
release in NGF-deprived sympathetic neurons. Sympathetic neurons were
immunostained with anti-cytochrome c antibody, and the neurons that
retained a punctate cytochrome c staining pattern (intact cytochrome c)
were counted under different conditions. CHX (1 µg/ml) and BAF (50 µM) were used as positive and negative control,
respectively. In medium supplemented with linopirdine (20 µM) and XE991 (10 µM), >90% neurons
maintained intact cytochrome c.
|
|
Linopirdine and XE991 inhibited the competence-to-die of
sympathetic neurons
We then examined whether linopirdine or XE991 prevented
sympathetic neuronal apoptosis by inhibiting the development of
competence-to-die (Deshmukh and Johnson, 1998 ). Sympathetic neurons
were deprived of NGF in the presence of linopirdine or XE991 for 36-48
hr. Parallel control cultures were deprived of NGF in the presence of
cycloheximide. To examine whether these neurons had developed
competence-to-die, cells were microinjected with mammalian cytochrome
c, and their survival was assessed at multiple time points after
cytosolic microinjection with mammalian cytochrome c. As reported
previously (Deshmukh and Johnson, 1998 ), the NGF-deprived,
cycloheximide-saved neurons developed "competence," because
microinjection of cytochrome c induced rapid cell death in these
neurons. In contrast, >80% of the linopirdine- or XE991-treated
neurons were alive even 12 hr after cytosolic microinjection of
cytochrome c (Fig. 7). The fact that
microinjection of cytochrome c did not induce cell death in the
presence of linopirdine or XE991 indicates that these neurons, although
deprived of NGF, had not developed competence-to-die. Thus, both
linopirdine and XE991 appear to block the pathway leading to the
development of competence-to-die during NGF deprivation.

View larger version (19K):
[in this window]
[in a new window]
|
Figure 7.
Linopirdine and XE991 inhibited the development of
competence-to-die in sympathetic neurons deprived of NGF. Sympathetic
neurons were maintained in NGF for 5 d and then deprived of NGF in
the presence of CHX (1 µg/ml; circles), linopirdine
(20 µM; triangles), or XE991 (10 µM; squares) for 36-48 hr. Cells were
microinjected with 15 mg/ml mammalian cytochrome c. At each time point
after the injection, the number of microinjected cells that remained
viable was determined and expressed as a percentage of the total number
of microinjected cells. Values represent mean ± SEM. More than
80% of the linopirdine-saved (triangles) or XE991-saved
(squares) neurons were alive, even 12 hr after cytosolic
microinjection of cytochrome c. In contrast, the NGF-deprived,
cycloheximide-saved neurons (circles) developed
competence as microinjection of cytochrome c induced rapid neuronal
death.
|
|
Increased intracellular calcium was correlated with sympathetic
neuronal survival in NGF deprivation
Intracellular Ca2+ concentration is
critical for survival in some cell death paradigms (Gallo et al., 1987 ;
Collins and Lile, 1989 ; Koike et al., 1989 ; Collins et al., 1991 ;
Franklin et al., 1995 ). We, therefore, investigated whether nifedipine
could reduce the capacity of M channel blockers to promote neuron
survival. Nifedipine dramatically reversed the protective effect of
linopirdine and XE991 (Fig. 8). When
nifedipine (100 nM) was added together with linopirdine (30 µM) or XE991 (50 µM) in NGF-deficient
medium, the protective effect of these K+
channel blockers was reduced by ~80%. Furthermore, nifedipine mostly reduced cell survival promoted by 40 mM
K+ in NGF-deprived medium; the survival
rate decreased from 80 to 20% in the presence of nifedipine.

View larger version (25K):
[in this window]
[in a new window]
|
Figure 8.
Nifedipine reversed the protective effect of
linopirdine or XE991 on NGF-deprived sympathetic neurons. Withdrawal of
NGF from the culture medium for 2 d caused widespread neuronal
death. Elevation of extracellular K+, 30 µM linopirdine, or 50 µM XE991 at the time
of NGF deprivation all show prominent neuroprotection. The L-type
Ca2+ channel antagonist nifedipine (100 nM) was able to primarily reverse the neuroprotective
effects induced by these three treatments. Cell survival was assayed 48 hr after incubation, cells were stained with toluidine blue, and live
cells were counted. Significant difference was determined with one-way
ANOVA, followed by Tukey's test. *p < 0.001 indicates significant difference from the control group with NGF;
#p < 0.001 indicates significant difference from
the corresponding group of deprived NGF plus the treatment without
nifedipine (i.e., the bar on the left).
n = 8 cultures for each testing group.
|
|
To better understand the role of Ca2+ in
neuronal survival of NGF deprivation, we next examined alterations in
[Ca2+]i after NGF
deprivation. After 12 hr treatment, NGF-deprived neurons showed a
statistically insignificant small decline in [Ca2+]i compared
with neurons maintained in NGF. However, there was a significant
increase in
[Ca2+]i in the
presence of linopirdine (20 µM) or XE991 (10 µM) over 12 hr in the NGF-deprived medium. The magnitude
of the [Ca2+]i
increase produced by linopirdine or XE991 was even greater when NGF was
present (Fig. 9). The
[Ca2+]i elevation
induced by either linopirdine or XE991 was prevented by the L-type
Ca2+ channel antagonist nifedipine (100 nM) (Fig. 9). On the other hand, the A-type
K+ channel blocker 4-AP (0.1 mM, 10-70 min) did not elevate
[Ca2+]i;
[Ca2+]i was
20 ± 4 and 9 ± 1 nM in control and 4-AP-treated
cells, respectively (n = 55 cells for each group;
p < 0.05).

View larger version (23K):
[in this window]
[in a new window]
|
Figure 9.
Increases in intracellular free
Ca2+ by linopirdine and XE991 and prevention by
nifedipine. NGF withdrawal did not cause a significant change in
[Ca2+]i measured by fura-2 imaging. In
NGF-deprived medium, linopirdine (20 µM) or XE991 (10 µM) raised [Ca2+]i
approximately twofold beyond the baseline. In NGF-maintained medium,
[Ca2+]i was increased approximately
threefold above the baseline by the same concentration of linopirdine
or XE991. The increase in [Ca2+]i was
eliminated by coapplied nifedipine (100 nM). Data were
taken from at least 100 cells. *p < 0.001 indicates significant difference from the basal level of
[Ca2+]i;
p < 0.001 indicates significant difference from
the corresponding group with NGF; #p < 0.001 indicates significant difference from the corresponding group without
nifedipine.
|
|
Effect of linopirdine and XE991 on membrane potential
To understand the mechanism by which the M channel blockers
elevated [Ca2+]i,
we determined the effect of linopirdine and XE991 on resting membrane
potential. When the membrane potential was measured using whole-cell
current clamp in the absence of TTX, frequent action potentials were
generated after application of linopirdine and XE991 (data not shown).
After 30-60 min exposure, the membrane potential was depolarized from
60.3 ± 2.3 to 47.3 ± 4.7 mV (p < 0.05) by linopirdine (20 µM) and from
64.6 ± 2.3 to 52.7 ± 2.8 mV (p < 0.05) by XE991 (10 µM), respectively (Fig.
10). The activity of
Na+ channels seemed critical for
linopirdine- and XE991-induced depolarization. When TTX (100 nM) was coapplied to block
Na+ channels, neither linopirdine nor
XE991 altered the resting membrane potential, even after several hours
of incubation (Fig. 10). Whereas prolonged incubation of 16-24 hr with
XE991 (10 µM) and TTX slightly depolarized the
membrane, prolonged incubation with linopirdine (20 µM) failed to induce any depolarization in the
presence of TTX (Fig. 10).

View larger version (23K):
[in this window]
[in a new window]
|
Figure 10.
Effects of linopirdine and XE991 on membrane
potential of sympathetic neurons and their dependence on activation of
Na+ channels. Sympathetic neurons were patched at
multiple time points for recording of membrane potentials during 1-24
hr treatments. A, Neurons were treated with sham wash or
exposed to 20 µM linopirdine or 10 µM XE991
for 10-60 min in the absence of TTX. Compared with the membrane
potential before drug application or the time-matched controls,
linopirdine and XE991 induced mild but significant depolarization after
30-60 min incubation (n = 3-10 cells for each
time point). B, When TTX (100 nM) was added
into the medium, there was no significant difference of membrane
potential between sham wash and linopirdine-treated cells during
several hours of incubation. Prolonged incubation of up to 24 hr with
XE991 induced a mild depolarization (n = 10-20
cells for each time point). Data shown in plots are from actual time
points. *p < 0.05 versus sham washing at same time
point; unpaired t test.
|
|
To test the contribution of Na+ channel
activation to Ca2+ homeostasis, we
measured changes in
[Ca2+]i after
acute application (60 min) of linopirdine (20 µM) or XE991 (10 µM) in the presence or absence of TTX (100 nM). TTX diminished the linopirdine-induced or
XE991-induced
[Ca2+]i
elevations, stabilizing
[Ca2+]i at or near
normal range during the incubation (Fig.
11). Consistent with the
[Ca2+]i data, the
neuroprotective effects of either linopirdine or XE991 were prevented
by coapplied TTX (Fig. 12).

View larger version (26K):
[in this window]
[in a new window]
|
Figure 11.
Effects of linopirdine and XE991 on
[Ca2+]i and their dependence on
activation of Na+ channels. Effects of linopirdine
and XE991 on [Ca2+]i in sympathetic
neurons were tracked by fura-2 imaging in the presence
(triangles) and absence (squares) of TTX.
A, Linopirdine (20 µM) alone caused a
gradual increase in [Ca2+]i
(n = 12 cells); the
[Ca2+]i increase was prevented by
coapplied TTX (100 nM; n = 14).
B, [Ca2+]i was raised
by XE991 (10 µM; n = 10), and the
effect was blocked by TTX (100 nM; n = 7).
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Figure 12.
Requirement of Na+ channel
activation in the protective effect of linopirdine and XE991 on
sympathetic neurons deprived of NGF. Substantial neuronal death was
induced by 2 d NGF withdrawal. In the presence or absence of NGF,
TTX (100 nM) alone showed little influence on cell
survival. Addition of 30 µM linopirdine or 50 µM XE991 promoted cell survival in the absence of NGF;
100 nM TTX abolished the neuroprotection induced by
linopirdine or XE991. Cell survival was assayed 48 hr after incubation,
cells were stained with toluidine blue, and live cells were counted.
n = 4 cultures for each group.
*p < 0.001 indicates significant difference from
the control with NGF; p < 0.05 indicates
significant difference from NGF deprived cells without antagonist;
#p < 0.05 indicates significant difference from
the corresponding group without TTX (i.e., the next bar
on the left).
|
|
 |
DISCUSSION |
The experiments described above demonstrate that
K+ channel blockers targeting the M-type
channel strongly promote sympathetic neuronal survival by activating
voltage-gated Na+ and
Ca2+ channels and increasing
[Ca2+]i. We
further reveal that interactions of these ion channels contribute to
the neuroprotection observed in sympathetic neurons.
Membrane depolarization and activation of voltage-gated
channels in the neuroprotection
The membrane depolarization caused by linopirdine and XE991 was
magnified by activation of voltage-gated
Na+ channels. Although we anticipated that
these drugs would block membrane K+
channels and depolarize the neurons directly, we saw little evidence for a membrane depolarization induced directly by blocking M channels. The small decrease in membrane potential in the presence of TTX was
insufficient to open voltage-gated calcium channels (Franklin et al.,
1995 ). Therefore, it appears that block of M channels by linopirdine
and XE991 requires activation of Na+
channels to amplify the depolarization and, consequently, to promote
Ca2+ entry via the L-type
Ca2+ channel and neuron survival. The
interdependence between activation of Ca2+
and Na+ channels in neuronal death and
survival has also been reported after traumatic axonal injury, in which
Na+ influx could subsequently trigger an
increase in
[Ca2+]i via the
opening of voltage-gated Ca2+ channels and
reversal of the
Na+-Ca2+
exchanger (Wolf et al., 2001 ).
Roles of calcium and potassium in the neuroprotection
The precise cellular mechanism(s) used by
[Ca2+]i to enhance
neuronal survival remain elusive. Translocation of cytochrome c and
development of competence-to-die could be directly inhibited by
elevated [Ca2+]i
(Putcha et al., 1999 ). We found that both linopirdine and XE991 block
the pathways leading to the release of cytochrome c and the development
of competence-to-die in sympathetic neurons under NGF deprivation. This
is consistent with previous observations that depolarization with
elevated extracellular K+ could block the
release of cytochrome c and development of competence-to-die (Putcha et
al., 1999 ). On the other hand, we are also intrigued by the observation
that [Ca2+]i does
not seem to decrease significantly after NGF is withdrawn for 12-16 hr
(Franklin et al., 1995 ) (Fig. 9). This suggests that NGF does not
necessarily maintain
[Ca2+]i; rather,
manipulations that elevate
[Ca2+]i above
normal levels are capable of substituting for the removal of the NGF.
Consequently, two separate trophic pathways may be present in the
sympathetic neurons: one requiring NGF and one dependent on elevated
[Ca2+]i. Very
large elevations in
[Ca2+]i are
neurotoxic, but these are well above the levels seen in the protected
sympathetic neurons (Hyrc et al., 1997 ).
The K+ hypothesis for apoptosis has been
proposed based on observations that an excessive
K+ efflux and intracellular
K+ depletion are early events in apoptotic
cascade and prerequisites for apoptotic shrinkage, caspase-3 cleavage,
and endonuclease activation (McCarthy and Cotter, 1997 ; Yu et al.,
1997 ; Dallaporta et al., 1998 ; Hughes and Cidlowski, 1999 ). The
K+ mechanism of apoptosis has been
implicated in cortical (Yu et al., 1997 , 1998 , 1999 ), hippocampal
(Nadeau et al., 2000 ), and basal forebrain cholinergic neurons (Colom
et al., 1998 ), as well as in peripheral cells such as lymphocytes
(Dallaporta et al., 1998 ; Hughes and Cidlowski, 1999 ). In the present
study, although nifedipine maintained
[Ca2+]i at the
resting level, it did not completely eliminate the neuroprotection by
linopirdine and XE991. It is possible that the residual ±20% neuronal
survival is attributable to attenuated K+
efflux. This might also explain the report that
Na+ channel activation delays sympathetic
neuronal death induced by NGF deprivation in the absence of calcium
entry (Tanaka and Koike, 1997 ). In this situation,
Na+ entry might enhance the activity of
the Na+,
K+-ATPase and preserve levels of
intracellular K+.
Based on available evidence, we currently believe that intracellular
Ca2+ and K+
both contribute to regulation of neuronal apoptosis; the dominant mechanism, however, may be different depending on the cell types and
apoptotic pathways involved (Yu et al., 2001 ). Specifically, the
Ca2+-dependent mechanism is likely the
principal mechanism for the protection against NGF deprivation-induced
apoptosis in sympathetic neurons.
M-type potassium channel block and
anti-apoptotic neuroprotection
The M channel is a G-protein-coupled
K+ channel inhibited by muscarinic
cholinergic agonists, originally described in bullfrog sympathetic
neurons (Brown and Adams, 1980 ). It is a voltage- and time-dependent,
low-threshold, non-inactivating channel, and the primary
K+ channel activated near the threshold
for Na+ channel activation and generation
of action potentials. The M channel, thus, plays important roles in
determining the membrane potential and membrane excitability. Our study
is the first report of an anti-apoptotic effect associated with
antagonism of this K+ channel. We conclude
that the neuroprotection achieved by linopirdine and XE991 is mainly
attributable to inhibition of the M channel based on the following
observations: (1) the half effective concentrations for M current block
and neuroprotection are both in low micromolar range; (2) at
concentrations that prevented ~50% neuronal death, linopirdine and
XE991 show no significant effect on other
K+ currents; and (3) linopirdine and XE991
have little anti-apoptotic effect in cultured cortical neurons that
have most major K+ currents but lack the M
current. On the other hand, because these two compounds inhibit
IK at high concentrations, their
powerful neuroprotection at these concentrations could involve block of IK and even other
K+ currents (Schnee and Brown, 1998 ). We
did not test the effects of low concentrations of linopirdine and XE991
on cytochrome c release and
[Ca2+]i increase;
however, based on their concentration-dependent neuroprotective effects
against apoptosis, it is reasonable to predict that these two cellular
events are likely affected by linopirdine and XE991 in
concentration-dependent manners.
Final remarks
The complicated interaction of several voltage-gated channels
leading to neuroprotection in these experiments was a surprise to us,
knowing that other investigators described previously exacerbation of
neuronal death by activation of voltage-gated
Na+ channels (Koike et al., 2000 ). Our
results illustrate the complex interrelationship between ion channel
activities and suggest that synchronized manipulation of
K+, Ca2+, and
Na+ channel activities may be necessary
for a neuroprotective reagent in a specific paradigm. Given the potency
and specificity of the two M-type K+
channel antagonists used in the present study, we predict that these or
similar drugs may offer a more practical approach to K+ channel blockade as a neuroprotective
strategy than elevation of extracellular
K+ or administration of lower potency and
less selective K+ channel antagonists.
 |
FOOTNOTES |
Received April 25, 2001; revised Oct. 17, 2001; accepted Oct. 22, 2001.
This work was supported by National Science Foundation Grant
IBN-9817151 (S.P.Y.), American Heart Association Grant 0170064N (S.P.Y.), and National Institutes of Health Grants NS37773 (S.M.R.) and
NS38651 (E.M.J.).
Correspondence should be addressed to Shan Ping Yu, Department of
Neurology and Center for the Study of Nervous System Injury, Box 8111, Washington School of Medicine, St. Louis, MO 63110. E-mail:
yus{at}neuro.wustl.edu.
M. Deshmukh's present address: Neuroscience Center, University of
North Carolina, Chapel Hill, NC 27599.
 |
REFERENCES |
-
Brown BS,
Yu SP
(2000)
Modulation and genetic identification of the M channel.
Prog Biophys Mol Biol
73:135-166[ISI][Medline].
-
Brown DA,
Adams PR
(1980)
Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone.
Nature
283:673-676[Medline].
-
Choi DW
(1996)
Ischemia-induced neuronal apoptosis.
Curr Opin Neurobiol
6:667-672[ISI][Medline].
-
Collins F,
Lile JD
(1989)
The role of dihydropyridine-sensitive voltage-gated calcium channels in potassium-mediated neuronal survival.
Brain Res
502:99-108[ISI][Medline].
-
Collins F,
Schmidt MF,
Guthrie PB,
Kater SB
(1991)
Sustained increase in intracellular calcium promotes neuronal survival.
J Neurosci
11:2582-2587[Abstract].
-
Colom LV,
Diaz ME,
Beers DR,
Neely A,
Xie WJ,
Appel SH
(1998)
Role of potassium channels in amyloid-induced cell death.
J Neurochem
70:1925-1934[ISI][Medline].
-
Costa AM,
Brown BS
(1997)
Inhibition of M-current in cultured rat superior cervical ganglia by linopirdine: mechanism of action studies.
Neuropharmacology
36:1747-1753[ISI][Medline].
-
Dallaporta B,
Hirsch T,
Susin SA,
Zamzami N,
Larochette N,
Brenner C,
Marzo I,
Kroemer G
(1998)
Potassium leakage during the apoptotic degradation phase.
J Immunol
160:5605-5615[Abstract/Free Full Text].
-
Deckwerth TL,
Johnson EM
(1993)
Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor.
J Cell Biol
123:1207-1222[Abstract/Free Full Text].
-
Deshmukh M,
Johnson EM
(1997)
Programmed cell death in neurons: focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons.
Mol Pharmacol
51:897-906[Abstract/Free Full Text].
-
Deshmukh M,
Johnson EM
(1998)
Evidence of a novel event during neuronal death: development of competence-to-die in response to cytoplasmic cytochrome c.
Neuron
21:695-705[ISI][Medline].
-
Deshmukh M,
Vasilakos J,
Deckwerth TL,
Lampe PA,
Shivers BD,
Johnson EM
(1996)
Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases.
J Cell Biol
135:1341-1354[Abstract/Free Full Text].
-
Easton RM,
Deckwerth TL,
Parsadanian AS,
Johnson EM
(1997)
Analysis of the mechanism of loss of trophic factor dependence associated with neuronal maturation: a phenotype indistinguishable from Bax deletion.
J Neurosci
17:9656-9666[Abstract/Free Full Text].
-
Edwards SN,
Buckmaster AE,
Tolkovsky AM
(1991)
The death programme in cultured sympathetic neurones can be suppressed at the posttranslational level by nerve growth factor, cyclic AMP, and depolarization.
J Neurochem
57:2140-2143[ISI][Medline].
-
Franklin JL,
Sanz-Rodriguez C,
Juhasz A,
Deckwerth TL,
Johnson EM
(1995)
Chronic depolarization prevents programmed death of sympathetic neurons in vitro but does not support growth: requirement for Ca2+ influx but not Trk activation.
J Neurosci
15:643-664[Abstract].
-
Galli C,
Meucci O,
Scorziello A,
Werge TM,
Calissano P,
Schettini G
(1995)
Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis.
J Neurosci
15:1172-1179[Abstract].
-
Gallo V,
Kingsbury A,
Balazs R,
Jorgensen OS
(1987)
The role of depolarization in the survival and differentiation of cerebellar granule cells in culture.
J Neurosci
7:2203-2213[Abstract].
-
Grynkiewicz G,
Poenie M,
Tsien RY
(1985)
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
J Biol Chem
260:3440-3450[Abstract/Free Full Text].
-
Henderson CE
(1996)
Programmed cell death in the developing nervous system.
Neuron
17:579-585[ISI][Medline].
-
Hughes FM,
Cidlowski JA
(1999)
Potassium is a critical regulator of apoptotic enzymes in vitro and in vivo.
Adv Enzyme Regul
39:157-171[ISI][Medline].
-
Hyrc K,
Handran SD,
Rothman SM,
Goldberg MP
(1997)
Ionized intracellular calcium concentration predicts excitotoxic neuronal death: observations with low-affinity fluorescent calcium indicators.
J Neurosci
17:6669-6677[Abstract/Free Full Text].
-
Johnson MI,
Argiro V
(1983)
Techniques in the tissue culture of rat sympathetic neurons.
Methods Enzymol
103:334-347[ISI][Medline].
-
Koike T,
Martin DP,
Johnson EM
(1989)
Role of Ca2+ channels in the ability of membrane depolarization to prevent neuronal death induced by trophic-factor deprivation: evidence that levels of internal Ca2+ determine nerve growth factor dependence of sympathetic ganglion cells.
Proc Natl Acad Sci USA
86:6421-6425[Abstract/Free Full Text].
-
Koike T,
Tanaka S,
Oda1 T,
Ninomiya T
(2000)
Sodium overload through voltage-dependent Na+ channels induces necrosis and apoptosis of rat superior cervical ganglion cells in vitro.
Brain Res Bull
51:345-355[Medline].
-
Kristufek D,
Koth G,
Motejlek A,
Schwarz K,
Huck S,
Boehm S
(1999)
Modulation of spontaneous and stimulation-evoked transmitter release from rat sympathetic neurons by the cognition enhancer linopirdine: insights into its mechanisms of action.
J Neurochem
72:2083-2091[Medline].
-
Martin DP,
Schmidt RE,
DiStefano PS,
Lowry OH,
Carter JG,
Johnson EM
(1988)
Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation.
J Cell Biol
106:829-844[Abstract/Free Full Text].
-
McCarthy JV,
Cotter TG
(1997)
Cell shrinkage and apoptosis: a role for potassium and sodium ion efflux.
Cell Death Differ
4:756-770.
-
McCarthy MJ,
Rubin LL,
Philpott KL
(1997)
Involvement of caspases in sympathetic neuron apoptosis.
J Cell Sci
110:2165-2173[Abstract].
-
Nadeau H,
McKinney S,
Anderson DJ,
Lester HA
(2000)
ROMK1 (Kir1.1) causes apoptosis and chronic silencing of hippocampal neurons.
J Neurophysiol
84:1062-1075[Abstract/Free Full Text].
-
Oppenheim RW
(1991)
Cell death during development of the nervous system.
Annu Rev Neurosci
14:453-501[ISI][Medline].
-
Pike CJ,
Balazs R,
Cotman CW
(1996)
Attenuation of beta-amyloid neurotoxicity in vitro by potassium-induced depolarization.
J Neurochem
67:1774-1777[ISI][Medline].
-
Putcha GV,
Deshmukh M,
Johnson EM
(1999)
BAX translocation is a critical event in neuronal apoptosis: regulation by neuroprotectants, BCL-2, and caspases.
J Neurosci
19:7476-7485[Abstract/Free Full Text].
-
Rose K,
Goldberg MP,
Choi DW
(1993)
Cytotoxicity in murine cortical cell culture.
In: Methods in toxicology, Vol 1, Pt A, In vitro biological methods, pp 46-60 San Diego: Academic.
-
Rydel RE,
Greene LA
(1988)
cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor.
Proc Natl Acad Sci USA
85:1257-1261[Abstract/Free Full Text].
-
Schnee ME,
Brown BS
(1998)
Selectivity of linopirdine (DuP 996), a neurotransmitter release enhancer, in blocking voltage-dependent and calcium-activated potassium currents in hippocampal neurons.
J Pharmacol Exp Ther
286:709-717[Abstract/Free Full Text].
-
Tanaka S,
Koike T
(1997)
Veratridine delays apoptotic neuronal death induced by NGF deprivation through a Na+-dependent mechanism in cultured rat sympathetic neurons.
Int J Dev Neurosci
15:15-27[Medline].
-
Tong JX,
Vogelbaum MA,
Drzymala RE,
Rich KM
(1997)
Radiation-induced apoptosis in dorsal root ganglion neurons.
J Neurocytol
26:771-777[ISI][Medline].
-
Wang HS,
Pan Z,
Shi W,
Brown BS,
Wymore RS,
Cohen IS,
Dixon JE,
McKinnon D
(1998)
KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.
Science
282:1890-1893[Abstract/Free Full Text].
-
Wang HS,
Brown BS,
McKinnon D,
Cohen IS
(2000)
Molecular basis for differential sensitivity of KCNQ and IKs channels to the cognitive enhancer XE991.
Mol Pharmacol
57:1218-1223[Abstract/Free Full Text].
-
Werth JL,
Deshmukh M,
Cocabo J,
Johnson EM,
Rothman SM
(2000)
Reversible physiological alterations in sympathetic neurons deprived of NGF but protected from apoptosis by caspase inhibition or Bax deletion.
Exp Neurol
161:203-211[ISI][Medline].
-
Wolf JA,
Stys PK,
Lusardi T,
Meaney D,
Smith DH
(2001)
Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels.
J Neurosci
21:1923-1930[Abstract/Free Full Text].
-
Yu SP
(1995)
Roles of arachidonic acid, lipoxygenases and phosphatases in calcium-dependent modulation of M-current in bullfrog sympathetic neurons.
J Physiol (Lond)
487:797-811[ISI][Medline].
-
Yu SP,
Yeh CH,
Sensi SL,
Gwag BJ,
Canzoniero LM,
Farhangrazi ZS,
Ying HS,
Tian M,
Dugan LL,
Choi DW
(1997)
Mediation of neuronal apoptosis by enhancement of outward potassium current.
Science
278:114-117[Abstract/Free Full Text].
-
Yu SP,
Farhangrazi ZS,
Ying HS,
Yeh CH,
Choi DW
(1998)
Enhancement of outward potassium current may participate in beta-amyloid peptide-induced cortical neuronal death.
Neurobiol Dis
5:81-88[ISI][Medline].
-
Yu SP,
Yeh CH,
Gottron F,
Wang X,
Grabb MC,
Choi DW
(1999)
Role of the outward delayed rectifier K+ current in ceramide-induced caspase activation and apoptosis in cultured cortical neurons.
J Neurochem
73:933-941[ISI][Medline].
-
Yu SP,
Canzoniero LMT,
Choi DW
(2001)
Ion homeostasis and apoptosis.
Cur Opin Cell Biol
13:405-411[ISI][Medline].
Copyright © 2002 Society for Neuroscience 0270-6474/02/221114-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
F. Schuetz, S. Kumar, P. Poronnik, and D. J. Adams
Regulation of the voltage-gated K+ channels KCNQ2/3 and KCNQ3/5 by serum- and glucocorticoid-regulated kinase-1
Am J Physiol Cell Physiol,
July 1, 2008;
295(1):
C73 - C80.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Prole, P. A. Lima, and N. V. Marrion
Mechanisms Underlying Modulation of Neuronal KCNQ2/KCNQ3 Potassium Channels by Extracellular Protons
J. Gen. Physiol.,
November& | |